Twin Lakes Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Twin Lakes Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	–	–	242
2024 Q4	–	Hold	0	–	–	–	239
2024 Q3	–	Hold	0	–	–	–	249
2024 Q2	–	Hold	0	–	–	–	245
2024 Q1	–	Hold	0	–	–	–	244
2023 Q4	–	Hold	0	–	–	–	257
2023 Q3	–	Hold	0	–	–	–	259
2023 Q2	–	Hold	0	–	–	–	245
2023 Q1	–	Hold	0	–	–	–	246
2022 Q4	–	Hold	0	–	–	–	246
2022 Q3	–	Hold	0	–	–	–	254
2022 Q2	–	Hold	0	–	–	–	268
2022 Q1	–	Hold	0	–	–	–	262
2021 Q4	–	Hold	0	–	–	–	256
2021 Q3	–	Hold	0	–	–	–	250
2021 Q2	–	Hold	0	–	–	–	230
2021 Q1	–	Hold	0	–	–	–	219

Other funds holding TNXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC Asset Management

CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return